ORBIMED ADVISORS LLC – PMV Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$78.10M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-16.49%
quarter
PMV Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -15.42M | $11.9 | 6.56M | |
| Q2 2022 | share | Decrease | -4.26% | -292.34K shares | -49.20M | $14.25 | 6.56M |
| Q1 2022 | share | Decrease | -6.48% | -475K shares | -26.60M | $20.82 | 6.85M |
| Q4 2021 | share | 0.00% | 0 shares | -49.11M | $23.51 | 7.33M | |
| Q3 2021 | share | 0.00% | 0 shares | -31.96M | $29.8 | 7.33M | |
| Q2 2021 | share | 0.00% | 0 shares | 9.30M | $34.16 | 7.33M | |
| Q1 2021 | share | 0.00% | 0 shares | -209.79M | $32.89 | 7.33M | |
| Q4 2020 | share | 0.00% | 0 shares | 190.66M | $61.51 | 7.33M | |
| Q3 2020 | share | Increase | 0.00% | 7.33M shares | 260.23M | $35.5 | 7.33M |